Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb;107(5):75-83; quiz 84.
doi: 10.3238/arztebl.2010.0075. Epub 2010 Feb 5.

Diabetic retinopathy: Early diagnosis and effective treatment

Affiliations
Review

Diabetic retinopathy: Early diagnosis and effective treatment

Aris N Kollias et al. Dtsch Arztebl Int. 2010 Feb.

Abstract

Background: Diabetic retinopathy is a microangiopathy of the retina from which nearly all persons with diabetes eventually suffer. Two of its complications threaten the patient's vision: diabetic macular edema and proliferative diabetic retinopathy.

Methods: Selective literature review, based on national and international guidelines and a literature search from 1981 onward.

Results: Diabetic retinopathy is subdivided into non-proliferative and proliferative retinopathy. Macular edema can arise at any stage of the disease and threatens visual acuity. The main risk factors for the development and progression of diabetic retinopathy are long duration of diabetes and poor control of blood sugar and arterial blood pressure. Laser photocoagulation is an evidence-based treatment for proliferative retinopathy and macular edema. Vitreous surgery is indicated in cases of worsening vision due to a non-clearing vitreous hemorrhage or tractional retinal detachment. The current options for medical treatment involve the intravitreous injection of glucocorticosteroids or of a VEGF antagonist; both of these options are "off label" at present.

Conclusion: Diabetic retinopathy is the leading cause of blindness among persons of working age in the industrialized world. Regular ophthalmological examinations, timely laser therapy depending on the stage of the disease, and close interdisciplinary cooperation are essential to prevent loss of vision.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic flowchart for the pathogenesis of diabetic retinopathy
Figure 2
Figure 2
Mild non-proliferative diabetic retinopathy with blot hemorrages, mainly on the temporal side of the macula, and clinically significant macular edema with hard exudates
Figure 3
Figure 3
Severe proliferative diabetic retinopathy with neovascularization on the optic disk and vitreous homorrhages
Figure 4
Figure 4
Neovascularization on the iridial surface extending from the edge of the pupil to the chamber angle
Figure 5
Figure 5
Severe proliferative diabetic retinopathy with neovascularization on the optic disk and epiretinal membranes with connective-tissue organization, elevating the retina
Figure 6
Figure 6
Proliferative diabetic retinopathy after panretinal laser coagulation

Comment in

  • Potentially dangerous treatment.
    Egidi G. Egidi G. Dtsch Arztebl Int. 2010 Jun;107(25):444; author reply 445. doi: 10.3238/arztebl.2010.0444a. Epub 2010 Jun 25. Dtsch Arztebl Int. 2010. PMID: 20644703 Free PMC article. No abstract available.
  • Rheohemapheresis may be successful.
    Otto J. Otto J. Dtsch Arztebl Int. 2010 Jun;107(25):444-5; author reply 445. doi: 10.3238/arztebl.2010.0444c. Epub 2010 Jun 25. Dtsch Arztebl Int. 2010. PMID: 20644704 Free PMC article. No abstract available.
  • Ultraviolet Irradiation.
    Frick G. Frick G. Dtsch Arztebl Int. 2010 Jun;107(25):444; author reply 445. doi: 10.3238/arztebl.2010.0444b. Epub 2010 Jun 25. Dtsch Arztebl Int. 2010. PMID: 20644705 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Hörle S, Grüner F, Kroll P. Epidemiologie diabetischer Erblindungen - eine Übersicht. Klin Monatsbl Augenheilkd. 2002;219(11):777–784. - PubMed
    1. Hamilton AMP, Ulbig MW, Polkinghome P. Management of diabetic retinopathy. London: BMJ Publishing Group; 1996.
    1. Jonas JB. Intravitreal Triamcinolone acetonide for diabetic retinopathy. Dev Ophthalmol. 2007;39:96–110. - PubMed
    1. Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study. Ophthalmology. 1991;98(Suppl 5):739–840. - PubMed
    1. Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2009;373:1364–1371. - PubMed